Guest guest Posted December 1, 2009 Report Share Posted December 1, 2009 Teresa Binstock <binstock Re: ot with iron & MS: Researcher's labour of love leads to MS break Posted by: "Liz" elizabethsoliday elizabethsoliday Mon Nov 30, 2009 7:12 am ((PST))Do you ever wonder, Teresa, if these researchers are actually ignorant to the fact that aluminum causes hemochromatosis (iron overload) or do you think they are purposely hiding the truth?I have not been aware than "aluminum causes hemochromatosis". Pubmed was not helpful. The search hemochromatosis AND aluminum generated 9 citations. 1: Szwarcberg J, Mack G, Flament J. [Ocular toxicity of deferoxamine: descriptionand analysis of three observations]. J Fr Ophtalmol. 2002 Jun;25(6):609-14.French. PubMed PMID: 12223949.2: McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. ArchOphthalmol. 1997 Jul;115(7):919-21. PubMed PMID: 9230837.3: Swartz RD, Legault DJ. Long-term intraperitoneal deferoxamine forhemochromatosis. Am J Med. 1996 Mar;100(3):308-12. PubMed PMID: 8629676.4: Iancu TC, Perl DP, Sternlieb I, Lerner A, Leshinsky E, Kolodny EH, Hsu A, GoodPF. The application of laser microprobe mass analysis to the study of biological material. Biometals. 1996 Jan;9(1):57-65. PubMed PMID: 8574093.5: Oshiro S. [A new inducible transferrin-independent iron uptake system involvedwith aluminum accumulation in the brain of patients with Alzheimer's disease].Tanpakushitsu Kakusan Koso. 1995 Aug;40(11):1738-43. Review. Japanese. PubMedPMID: 7676035.6: el-Reshaid K, Johny KV, Hakim A, Kamel H, Sebeta A, Hourani H, Kanyike FB.Erythropoietin treatment in haemodialysis patients with iron overload. ActaHaematol. 1994;91(3):130-5. PubMed PMID: 8091934.7: Rosenlöf K, Grönhagen-Riska C, Sovijärvi A, Honkanen E, Tikkanen I, EkstrandA, Piirilä P, Fyhrquist F. Beneficial effects of erythropoietin on haematologicalparameters, aerobic capacity, and body fluid composition in patients onhaemodialysis. J Intern Med. 1989 Nov;226(5):311-7. PubMed PMID: 2809506.8: Allain P, Mauras Y, Chaleil D, Simon P, Ang KS, Cam G, Le Mignon L, Simon M.Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine inhealthy subjects and patients with haemochromatosis. Br J Clin Pharmacol. 1987Aug;24(2):207-12. PubMed PMID: 3620295; PubMed Central PMCID: PMC1387751.9: Braunstein EM, Menerey K, Martel W, Swartz R, Fox IH. Radiologic features of apyrophosphate-like arthropathy associated with long-term dialysis. SkeletalRadiol. 1987;16(6):437-41. PubMed PMID: 2821626.Sheri Nakken, R.N., MA, Hahnemannian Homeopath Vaccination Information & Choice Network, Washington State, USAVaccines - http://www.nccn.net/~wwithin/vaccine.htm or http://www.wellwithin1.com/vaccine.htmVaccine Dangers, Childhood Disease Classes & Homeopathy Online/email courses - next classes start December 2 & 3http://www.wellwithin1.com/vaccineclass.htm or http://www.wellwithin1.com/homeo.htm Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.